A Post Market Trial Assessing the Accuracy of Normal Mode Reading vs. ProScan Reading With the NaviCam SB System. This is a Comparison of Retrospectively Obtained Capsule Endoscopy Videos With a New AI Reading Tool; no New Interventions Will be Completed.

Part of paid clinical trials in New York, New York.

Sponsor
AnX Robotica Corp.
Study ID
NCT07633847
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Small Bowel Bleeding

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Video capsule endoscopy — DEVICE
    Phase I = Data Collection. The video from the capsule endoscopy procedure will be reviewed and reported by the treating physician. Once the capsule has passed and any adverse events have been collected, there will be no additional patient follow-up.
  • Phase II = Data analysis by Independent Readers — OTHER
    Independent video capsule readers to review and evaluate the videos from the capsule endoscopy procedure (Phase I), plus the ProScan videos.
  • Phase III = Data Analysis by Expert Readers — OTHER
    An Expert Panel will read all videos to create a database comparing the Physician results (Phase I) and the ProScan + Physician results (Phase II).

Study Details

NaviCam ProScan is an artificial intelligent (AI) assisted reading tool designed to aid small bowel capsule endoscopy reviewers in decreasing the time to review capsule endoscopy images for adult patients in whom the capsule endoscopy images were obtained for suspected small bowel bleeding.

Key Dates

Start date
Jun 15, 2026
Status verified
Jun 2026
Primary completion
Jun 15, 2028
Completion
Sep 15, 2028

Study Design

Enrollment
92 participants (estimated)

Arms

  • Arm: NaviCam VCE (video capsule endoscopy)
    Adults 22 years of age or older who received a NaviCam capsule endoscopy procedure

Primary Outcome Measure

Subject-level sensitivity [ Time Frame: 24 months ]

Central Contacts

Locations (3)

FacilityCityStateZIP
NYU Grossman School of MedicineNew YorkNew York10022
NYU Langone HealthNew YorkNew York10016
Digestive Health Associates of TexasBedfordTexas76002

Find similar trials in New York, NY